EYA3 Activators
The chemical class known as EYA3 Activators comprises a diverse array of compounds selected for their potential to influence the activity of EYA3, a protein encoded by the EYA3 gene. While precise direct activators for EYA3 may not be explicitly delineated, these compounds operate through intricate interactions with signaling pathways and cellular processes, offering insights into potential mechanisms for influencing EYA3 activity. Activators of this class can stimulate adenylate cyclase, thereby elevating intracellular cAMP levels. This increase in cAMP levels activates protein kinase A (PKA), which has the potential to phosphorylate and modulate the activity of EYA3. By impacting EYA3 at the post-translational level, forskolin may contribute to the regulation of cellular processes influenced by EYA3.
EYA3 Activators may operate as a protein tyrosine phosphatase inhibitor. By inhibiting phosphatases that may negatively regulate EYA3, sodium orthovanadate can potentially enhance the phosphorylation status of EYA3, indirectly activating it in cellular signaling pathways. This regulation of EYA3 phosphorylation may impact its role in various cellular processes, providing a potential avenue for EYA3 activation. Additionally, activators may promote EYA3 by inhibiting tyrosine phosphatases, contributing to the modulation of EYA3 activity and its involvement in cellular signaling cascades. These compounds collectively exemplify the diverse strategies within the chemical class of EYA3 activators, highlighting their potential to influence EYA3 function through various signaling pathways and cellular processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can activate EYA3 by stimulating adenylate cyclase, leading to increased cAMP levels. Elevated cAMP levels activate protein kinase A (PKA), which can potentially phosphorylate and modulate EYA3 activity, impacting cellular processes influenced by EYA3. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a protein tyrosine phosphatase inhibitor. By inhibiting phosphatases that may negatively regulate EYA3, it can potentially increase the phosphorylation status of EYA3 and enhance its activity in cellular signaling pathways, indirectly activating EYA3. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin, a flavonoid, can potentially activate EYA3 by inhibiting tyrosine phosphatases. Through its ability to modulate the activity of phosphatases, apigenin may contribute to maintaining the phosphorylation state of EYA3, influencing its function in cellular processes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate (EGCG) 989-51-5 EGCG, a polyphenol in green tea, may activate EYA3 by inhibiting tyrosine phosphatases. By regulating phosphatase activity, EGCG can potentially enhance the phosphorylation status of EYA3, affecting its role in various cellular signaling pathways and promoting its activation. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $79.00 $321.00 $671.00 | 1 | |
Indirubin-3'-monoxime 160807-49-8 Indirubin-3'-monoxime is a CDK inhibitor. By inhibiting CDKs, it can potentially activate EYAThe inhibition of CDKs may lead to altered phosphorylation patterns of EYA3, influencing its activity and involvement in cellular processes. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid, a protein phosphatase inhibitor, can potentially activate EYA3 by preventing the dephosphorylation of EYAInhibition of protein phosphatases may contribute to the maintenance of EYA3 phosphorylation, impacting its activity in cellular processes and potentially promoting EYA3 activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase (HDAC) inhibitor, may activate EYA3 by influencing epigenetic regulation. HDAC inhibition can lead to changes in chromatin structure, potentially affecting the transcriptional regulation of EYA3 and promoting its activation in cellular processes influenced by epigenetic modifications. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK (Rho-associated protein kinase) inhibitor. By inhibiting ROCK, it can potentially activate EYA3 through the modulation of Rho signaling. The inhibition of ROCK may influence cellular processes related to EYA3 activation, contributing to the potential activation of EYA3 in these signaling pathways. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Trametinib, a MEK inhibitor, can potentially activate EYA3 by impacting the MAPK/ERK pathway. Inhibition of MEK influences downstream signaling events, potentially affecting the regulation of EYA3 and promoting its activation in cellular processes associated with the MAPK/ERK pathway. | ||||||